Kennedy PJ - Search Results

1

Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier.

Gomes MJ, Kennedy PJ, Martins S, Sarmento B. Gomes MJ, et al. Among authors: kennedy pj. Nanomedicine (Lond). 2017 Jun;12(12):1385-1399. doi: 10.2217/nnm-2017-0023. Epub 2017 May 19. Nanomedicine (Lond). 2017. PMID: 28524759

2

Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells.

Pereira I, Sousa F, Kennedy P, Sarmento B. Pereira I, et al. Int J Pharm. 2018 Oct 5;549(1-2):397-403. doi: 10.1016/j.ijpharm.2018.08.016. Epub 2018 Aug 12. Int J Pharm. 2018. PMID: 30110619

3

Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?

Sousa F, Castro P, Fonte P, Kennedy PJ, Neves-Petersen MT, Sarmento B. Sousa F, et al. Among authors: kennedy pj. Expert Opin Drug Deliv. 2017 Oct;14(10):1163-1176. doi: 10.1080/17425247.2017.1273345. Epub 2016 Dec 29. Expert Opin Drug Deliv. 2017. PMID: 28005451 Review.

4

Antibodies and associates: Partners in targeted drug delivery.

Kennedy PJ, Oliveira C, Granja PL, Sarmento B. Kennedy PJ, et al. Pharmacol Ther. 2017 Sep;177:129-145. doi: 10.1016/j.pharmthera.2017.03.004. Epub 2017 Mar 14. Pharmacol Ther. 2017. PMID: 28315359 Review.

5

A comprehensive review of the neonatal Fc receptor and its application in drug delivery.

Martins JP, Kennedy PJ, Santos HA, Barrias C, Sarmento B. Martins JP, et al. Among authors: kennedy pj. Pharmacol Ther. 2016 May;161:22-39. doi: 10.1016/j.pharmthera.2016.03.007. Epub 2016 Mar 22. Pharmacol Ther. 2016. PMID: 27016466 Review.

6

Monoclonal antibodies: technologies for early discovery and engineering.

Kennedy PJ, Oliveira C, Granja PL, Sarmento B. Kennedy PJ, et al. Crit Rev Biotechnol. 2018 May;38(3):394-408. doi: 10.1080/07388551.2017.1357002. Epub 2017 Aug 8. Crit Rev Biotechnol. 2018. PMID: 28789584 Review.

7

Polyester-Based Nanoparticles for the Encapsulation of Monoclonal Antibodies.

Sousa F, Fonte P, Cruz A, Kennedy PJ, Pinto IM, Sarmento B. Sousa F, et al. Among authors: kennedy pj. Methods Mol Biol. 2018;1674:239-253. doi: 10.1007/978-1-4939-7312-5_20. Methods Mol Biol. 2018. PMID: 28921443

8

Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.

Kennedy PJ, Perreira I, Ferreira D, Nestor M, Oliveira C, Granja PL, Sarmento B. Kennedy PJ, et al. Eur J Pharm Biopharm. 2018 Jun;127:366-370. doi: 10.1016/j.ejpb.2018.03.005. Epub 2018 Mar 13. Eur J Pharm Biopharm. 2018. PMID: 29549023

9

Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.

Kennedy PJ, Sousa F, Ferreira D, Pereira C, Nestor M, Oliveira C, Granja PL, Sarmento B. Kennedy PJ, et al. Acta Biomater. 2018 Nov;81:208-218. doi: 10.1016/j.actbio.2018.09.043. Epub 2018 Sep 27. Acta Biomater. 2018. PMID: 30267881

10

Use of Photosensitizers in Semisolid Formulations for Microbial Photodynamic Inactivation.

González-Delgado JA, Kennedy PJ, Ferreira M, Tomé JP, Sarmento B. González-Delgado JA, et al. Among authors: kennedy pj. J Med Chem. 2016 May 26;59(10):4428-42. doi: 10.1021/acs.jmedchem.5b01129. Epub 2015 Dec 1. J Med Chem. 2016. PMID: 26569024 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters